Invesco

Invesco’s Ginkgo Bioworks DNA Stock Holding History

Invesco’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.44M	Sell	234,808 -26,898	-10%	-$224K	﹤0.01%	2703
2025 Q4	$2.17M	Buy	261,706 +50,565	+24%	+$544K	﹤0.01%	2581
2025 Q3	$3.08M	Buy	211,141 +51,336	+32%	+$614K	﹤0.01%	2447
2025 Q2	$1.8M	Buy	159,805 +66,121	+71%	+$512K	﹤0.01%	2608
2025 Q1	$534K	Buy	93,684 +67,130	+253%	+$684K	﹤0.01%	3122
2024 Q4	$261K	Sell	26,554 -160	-0.6%	-$1.37K	﹤0.01%	3456
2024 Q3	$218K	Sell	26,714 -430	-2%	-$4.31K	﹤0.01%	3496
2024 Q2	$363K	Sell	27,144 -28,367	-51%	-$846K	﹤0.01%	3421
2024 Q1	$2.58M	Buy	55,511 +17,545	+46%	+$908K	﹤0.01%	2549
2023 Q4	$2.57M	Buy	37,966 +2,321	+7%	+$142K	﹤0.01%	2524
2023 Q3	$2.58M	Buy	35,645 +314	+0.9%	+$25.1K	﹤0.01%	2505
2023 Q2	$2.63M	Buy	35,331 +3,702	+12%	+$219K	﹤0.01%	2548
2023 Q1	$1.68M	Buy	31,629 +14,879	+89%	+$943K	﹤0.01%	2704
2022 Q4	$1.13M	Buy	16,750 +3,018	+22%	+$278K	﹤0.01%	2878
2022 Q3	$1.71M	Sell	13,732 -1,184	-8%	-$141K	﹤0.01%	2706
2022 Q2	$1.42M	Buy	+14,916	New	+$1.82M	﹤0.01%	2851

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return